Dr. Catriona Jamieson.Sanford Consortium for Regenerative Medicine.Stem cell laboratory.Moores Cancer Center.

Welcome to the Division of Regenerative Medicine

We are dedicated to delivering superb state-of-the-art clinical care and bringing the advancement of scientific research in regenerative medicine to the forefront of public and scientific spheres both locally and globally. We study vaccines, therapies, diagnostics, cures and research technologies to relieve human suffering from chronic disease and injury.

News

Recent news and advances:

The Division of Regenerative Medicine held its inagural First Friday Socials at Bella Vista Caffe on November 3, 2017. See photos from the event here

 Congratulations to our Chief, Catriona Jamieson! She was honored on September 19, 2017 as the Koman Family Presidental Endowed Chair for Cancer Research. See some highlights from the event here

The Division of Regenerative Medicine held its inagural Summer Retreat on August 25, 2017.  See photos from the event here.

Join the DRM as they host a seminar talk given by Dr. Carl June, renowned CAR T cells expert, on Tuesday, June 20, 2017 at 10:00am at the Roth Auditorium, La Jolla, CA. View more information here. JuneFlyer.pdf

Jeremy Rich, MD, MHS, MBA has joined the Division of Regenerative Medicine as Professor of Medicine. Dr. Rich will also serve as Director of Neuro-Oncology and Director of the Brain Tumor Institute at UC San Diego. View more about this appointment here



Meet Jeremy Rich, MD, MHS, MBA


Jeremy Rich, MD, MHS, MBA, has joined the Division of Regenerative Medicine as Professor of Medicine, Director of Neuro-Oncology and Director of the Brain Tumor Institute.

The goals of the Rich laboratory are to identify novel therapeutic paradigms in the treatment of advanced cancers, primarily malignant brain tumors, through the understanding of a stem cell-like phenotype found in many cancers and core signal transduction pathways amenable to pharmacologic targeting.  The aim is to seek to better understand the clinical relevance of cancer stem cells and the interaction with the tumor microenvironment and underlying genetic driver mutations in human cancers.

Dr. Rich also provides clinical care for patients afflicted with primary and metastatic nervous system cancers.

 

Meet Leslie Crews, PhD

                                                                                          

Leslie Crews, PhD, has joined the Division of Regenerative Medicine as Assistant Adjunct Professor of Medicine.

                                                                              The ongoing research in the Crews Laboratory aims to investigate the function of cancer stem cells in multiple myeloma progression and relapse.  In recent work, with the Jamieson laboratory, they have identified a role for inflammation responsive pathways in the acquisition of drug resistance and stem cell-like behavior of malignant cells in multiple myeloma.